Dr. Kate Papp, an assistant professor in neurology at Harvard Medical School, specializes in the neuropsychological aspects of aging and Alzheimer's disease. In her recent webinar, Dr. Papp delved into the challenges of conducting digital cognitive assessments in preclinical stages of Alzheimer's. She critiqued the limitations of traditional paper-and-pencil assessments and explored contemporary approaches that include the use of big data and artificial intelligence. Dr. Papp emphasized the value of serial assessments and argued for more sensitive, digitally-enabled methods for early detection of cognitive decline in Alzheimer's patients.